Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity (Q45788517)
Jump to navigation
Jump to search
scientific article published on November 1, 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity |
scientific article published on November 1, 1995 |
Statements
1 reference
Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity (English)
1 reference
Z. P. Bernstein
M. M. Porter
M. Gould
B. Lipman
E. M. Bluman
C. C. Stewart
R. G. Hewitt
G. Fyfe
B. Poiesz
1 November 1995
1 reference
1 reference
86
1 reference
9
1 reference
3287-3294
1 reference
Identifiers
1 reference